Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Explore effective wealth building strategies during an economic downturn. Invest wisely to secure your financial future now.
20,519 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A pipeline-focused ETF is drawing retirees with its steady monthly payouts, delivering roughly 7.8% annual yield and ...
Applied Materials just ripped higher again, sparking a profit-taking debate as the stock taps fresh highs. This repor...
Most altcoins remain in a prolonged downturn as markets grapple with breadth, volatility, and cautious investor senti...
As markets shift in 2026, retirees face a costly misstep: pulling from your 401(K) early. Experts say tapping taxable...
Anthropic reports that the Trump administration has removed major usage restrictions on Claude Fable 5 and Mythos 5. ...
US spot Bitcoin ETFs posted another day of outflows on June 30, extending a nine-day streak and signaling a broader c...
More than 1,700 UK investors filed a High Court group claim against Binance and Changpeng Zhao, alleging sales of hig...
Five pivotal reverse mortgage stories from the first half of 2026 reveal how policy debates, consumer protections, an...
AeroVironment stock climbed today after a major government contract announcement. This article breaks down what happe...
Two benchmarks gave two opposite results for Claude Fable 5. The mystery isn't a nerf—it's the routing layer. Learn h...
Costco has publicly reaffirmed that the iconic $1.50 hot dog and soda combo will stay at its current price, signaling...